Stockscreener 앱 받기
5.09
5.91%
-0.32
시간 외 거래:
5.13
0.04
+0.79%
Wave Life Sciences Ltd 주식(WVE)의 최신 뉴스
Wave Life Sciences Ltd. SEC Filing (Aug 17, 2026) - Stock Titan
Precision Trading with Wave Life Sciences Ltd. (WVE) Risk Zones - Stock Traders Daily
WVE Stock Edges Up After Positive Early Data For Rare Disease Drug - Stocktwits
Wave Life Sciences, Inc.: Top Mutual Funds Holders | WVE | US94352A1043 - marketscreener.com
Wave Life Sciences, Inc.: Target Price Consensus and Analysts Recommendations | WVE | US94352A1043 - marketscreener.com
Wave Life Sciences, Inc.: Performance & Quotes, WVE Stock Price on Nasdaq Exchange - marketscreener.com
Wave Life Sciences, Inc.: Fundamental Analysis and Financial Ratings | WVE | US94352A1043 - marketscreener.com
Wave Life Sciences, Inc.: Financial Data Forecasts Estimates and Expectations | WVE | US94352A1043 - marketscreener.com
What Went Wrong For WVE? The Obesity Drug Trial Data That Spooked Investors - Stocktwits
Q2 2026 WAVE Life Sciences Ltd Earnings Call Transcript - GuruFocus
Wave Life Sciences Ltd.: Revenue and Earnings Analysts Forecasts Revisions | WVE | US94352A1043 - marketscreener.com
Wave Life Sciences (WVE) Director Adrian Rawcliffe Sells 12,700 Shares, Reducing Stake to Zero - GuruFocus
WAVE Life Sciences (NASDAQ:WVE) Director Adrian Rawcliffe Sells 12,700 Shares - MarketBeat
Ken Takanashi Sells 3,864 Shares of WAVE Life Sciences (NASDAQ:WVE) Stock - MarketBeat
Wave Life Sciences (WVE) director’s 3,864-share tax sale under 10b5-1 plan - Stock Titan
Wave Life Sciences: A $1 Billion RNA-Medicine Bargain Ripe for Pharma Takeover - Yahoo Finance
Wave Life Sciences (WVE) Stock Looks Cheap After A 68% Fall But Expensive On Sales - simplywall.st
Wave Life Sciences Ltd. SEC Filing (Aug 12, 2026) - Stock Titan
Wave Life Sciences at canaccord growth conference: obesity and RNA bets - Investing.com Canada
BofA Securities Maintains Wave Life Sciences(WVE.US) With Buy Rating, Maintains Target Price $17 - Moomoo
WAVE Life Sciences (NASDAQ:WVE) Hits New 52-Week LowHere's What Happened - MarketBeat
Wave Life Sciences: An Fairly Valued RNA Opportunity - Seeking Alpha
Wave Life Sciences stock hits 52-week low at $5.01 By Investing.com - Investing.com Australia
RA Capital group discloses 16.8% Wave Life Sciences (WVE) ownership after redomiciliation - Stock Titan
Wave Life Sciences Ltd. SEC Filing (Aug 11, 2026) - Stock Titan
Wave Life Sciences stock hits 52-week low at $5.01 - Investing.com
Wave Life Sciences at Bank of America SMID Cap Virtual Conference: pipeline bets - Investing.com Nigeria
WAVE Life Sciences (NASDAQ:WVE) Stock Price Down 6.8%Should You Sell? - MarketBeat
WAVE Life Sciences Ltd at RBC Capital Markets Global Healthcare Conference Transcript - GuruFocus
Q2 2025 WAVE Life Sciences Ltd Earnings Call Transcript - GuruFocus
Wave Life Sciences Inc (FRA:0VS) Stock Earnings Transcripts - GuruFocus
Wave Life Sciences Ltd. (WVE) Stock Analysis: Exploring A 214% Upside In Biotech's Future - DirectorsTalk Interviews
WAVE Life Sciences: Target Price Consensus and Analysts Recommendations | WVE | US94352A1043 - marketscreener.com
WAVE Life Sciences: Fundamental Analysis and Financial Ratings | WVE | US94352A1043 - marketscreener.com
WAVE Life Sciences: Financial Data Forecasts Estimates and Expectations | WVE | US94352A1043 - marketscreener.com
Analysts Just Made A Major Revision To Their Wave Life Sciences Ltd. (NASDAQ:WVE) Revenue Forecasts - webull.com
WAVE Life Sciences (NASDAQ:WVE) Shares Gap UpHere's Why - MarketBeat
Wave Life Sciences Completes Redomiciliation to Delaware - marketscreener.com
Wave Life Sciences completes redomiciliation to Delaware By Investing.com - Investing.com Australia
Wave Life Sciences Completes Redomiciliation From Singapore to Delaware - citybiz
Wave Life Sciences completes redomiciliation to Delaware - Investing.com
Wave Life Sciences Announces Completion of Redomiciliation to Delaware Corporation - Quiver Quantitative
Wave Life Sciences Announces Completion of Redomiciliation to Delaware - The Manila Times
Wave Life Sciences Announces Completion of Redomiciliation to Delaware | Associated Press | syndication news - Enidnews.com
Wave Life Sciences Keeps WVE Ticker After Delaware Parent Move - Stock Titan
Wave Life Sciences (WVE) refreshes $250M ATM and shelf after Delaware redomicile - Stock Titan
WAVE Life Sciences Ltd (WVE) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
WAVE Life Sciences Ltd. (NASDAQ:WVE) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Wave Life Sciences completes redomiciliation to Delaware, new parent entity to trade on Nasdaq - Investing.com UK
Wave Life Sciences Ltd. SEC Filing (Aug 7, 2026) - stocktitan.net
Wave Life Sciences (WVE) files prospectus for 7.1M-share stockholder resale - Stock Titan
Form 8K Wave Life Sciences For: 7 August By Investing.com - Investing.com Nigeria
Did U.S. Redomiciliation and Mixed 1H 2026 Results Just Shift Wave Life Sciences' (WVE) Investment Narrative? - Yahoo Finance
WAVE Life Sciences Ltd. $WVE Shares Purchased by Renaissance Technologies LLC - MarketBeat
Wave Life Sciences redomiciliation to U.S. set for Friday - Investing.com
Wave Life Sciences redomiciliation to U.S. set for Friday By Investing.com - Investing.com Canada
Wave Life Sciences Announces Expected Completion Date for Redomiciliation to Delaware - manilatimes.net
Singapore High Court approves scheme for Wave Life Sciences’ Delaware move - Stock Titan
Wave Life Sciences to Present at Upcoming Investor Conferences - manilatimes.net
1.80%
1.77%
자본화:
|
볼륨(24시간):